Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda

Journal of Infectious Diseases

Volumn 185, Issue 9, 2002, Pages 1244-1250

  Kaleebu, Pontiano ^a   French, Neil ^a,b   Mahe, Cedric ^a   Yirrell, David ^c   Watera, Christine ^a   Lyagoba, Fred ^a   Nakiyingi, Jessica ^a   Rutebemberwa, Alleluiah ^a   Morgan, Dilys ^a   Weber, Jonathan ^d   Gilks, Charles ^b   Whitworth, Jimmy ^a  

^a UGANDA VIRUS RESEARCH INSTITUTE   (Uganda)

^b LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^c UNIVERSITY OF EDINBURGH   (United Kingdom)

^d IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SURVIVAL RATE; UGANDA; VIRUS ENVELOPE; VIRUS INFECTION; VIRUS TYPING;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; AGED; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HIV-1; HUMANS; MALE; MIDDLE AGED; UGANDA;

EID: 0036569329     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/340130     Document Type: Article

References (43)

1. Origins and diversity of human immunodeficiency viruses
2. Sequence analysis of the V3 loop regions of the env genes of Ugandan human immunodeficiency provirus
3. Ugandan HIV-1 V3 loop sequences closely related to the US/European consensus
4. Rapid genetic charaterisation of HIV type 1 strains from four World Health Organisation-sponsored vaccine evaluation sites using heteroduplex mobility assay
5. Presence of multiple genetic subtypes of human immunodeficiency virus type 1 proviruses in Uganda
6. Identification of HIV-1 subtype G from Uganda
7. Heteroduplex mobility assay and phylogenetic analysis of V3 region sequences of human immunodeficiency virus type 1 isolates from Gulu, northern Uganda
8. Serologic and phylogenetic characterisation of HIV-1 subtypes in Uganda
9. A molecular epidemiological survey of HIV in Uganda
10. Molecular epidemiological analysis of HIV in sexual networks in Uganda
11. Molecular epidemiology of HIV-1 in a rural community in southwest Uganda
12. An improved algorithm for determining HIV-1 subtypes in a primary laboratory in Uganda
13. Identification of diverse HIV type 1 subtypes and dual HIV type 1 infection in pregnant Ugandan women
14. Predominance of HIV-1 subtypes A and D infections in Uganda
15. Genetic characterisation and phylogenetic analysis of HIV-1 subtype C from Uganda
16. Inter- and intra-genic intersubtype HIV-1 recombination in rural and semi-urban Uganda
17. HIV-1 subtypes: Implications for epidemiology, pathogenicity, vaccines and diagnostics. Workshop Report from European Commission (DG XII, INCO-DC) and the Joint United Nations Programme on HIV/AIDS
18. African HIV-1 subtype C and rate of progression among Ethiopian immigrants in Israel
19. Human immunodeficiency virus type 1 subtypes differ in disease progression
20. What role does HIV-1 subtype play in transmission and pathogenesis? An epidemiological perspective
21. Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D
22. Clinical disease associated with HIV-1 subtype B and E infection among 2104 patients in Thailand
23. Relationship between HIV-1 env subtypes A and D and disease progression in a rural Ugandan cohort
24. HIV disease progression and V3 serotypes in Brazil: Is B different from B-Br?
25. Subtypes of human immunodeficiency virus type 1 and disease stage among women in Nairobi, Kenya
26. Viral load differences in early infection with two HIV-1 subtypes
27. The stability between two HIV-1 RNA measurements one year apart and the relationship with HIV subtype in rural Uganda
28. Syncytium-inducing and non-syncytium inducing capacity of human immunodeficiency virus type 1 subtypes other than B: Phenotype and genotype characteristics
29. Differences in chemokine coreceptor usage between genetic subtypes of HIV-1
30. HIV-1 disease progression and AIDS-defining disorders in rural Uganda
31. Immunological and clinical stages in HIV-1 infected Ugandan adults are comparable and provide no evidence of rapid progression but poor survival with advanced disease
32. Macrophage and T cell-line tropism of HIV are determined by specific regions of the envelope gp120 gene
33. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1
34. Phenotype-associated sequence variation in the third variable region of human immunodeficiency virus type 1 gp120 molecule
35. Human immunodeficiency virus type 1 neutralisation epitope with conserved architecture elicits early type-specific antibodies in experimentally infected chimpanzees
36. An immunodominant epitope of human immunodeficiency virus envelope glycoprotein gp160 recognized by class 1 major histocompatibility complex molecule-restricted murine cytotoxic T lymphocyte
37. 23-Valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults: Double-blind, randomised and placebo controlled trial
38. Proposed World Health Organization staging system for HIV infection and disease: Preliminary testing by an international collaborative cross-sectional study
39. Genetic subtyping of human immunodeficiency virus using heteroduplex mobility assay
40. Longitudinal data analysis using generalized linear models
41. The prognostic value of the World Health Organization staging system for HIV infection and disease in rural Uganda
42. HIV-1 infection in rural Africa - Is there a difference in time to AIDS and survival compared with that in industrialized countries?